ArticleJournal of shoulder and elbow arthroplasty2026
Ninety-day venous thromboembolism incidence and associated risk factors after total and reverse shoulder arthroplasty: a national database analysis.
Article in Journal of shoulder and elbow arthroplasty, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, is an uncommon but potentially serious complication following total shoulder arthroplasty. This study evaluated patient factors associated with post-operative (PO) VTE after anatomic total shoulder arthroplasty (aTSA) and reverse total shoulder arthroplasty (rTSA). Methods: A retrospective cohort study was performed using the PearlDiver database. Patients undergoing primary aTSA or rTSA with at least 120 days of follow-up were identified using International Classification of Diseases, 10th edition procedure codes. VTE within 90 days post-operatively was the primary outcome. Logistic regression evaluated demographic characteristics, comorbidities, length of stay, Charlson Comorbidity Index, and prior VTE history as predictors of PO VTE. Results: A total of 42,014 patients underwent aTSA and 93,358 underwent rTSA. PO VTE occurred in 256 (0.61%) patients after aTSA and 767 (0.82%) after rTSA. Increased length of stay, higher Charlson Comorbidity Index, obesity, congestive heart failure, prior valve replacement, renal disease, hepatobiliary disease, and pulmonary disease were associated with increased odds of VTE following both procedures. Diabetes, coronary artery disease, hypertension, malignancy, and rheumatoid arthritis were additional risk factors following rTSA. Among 4,576 patients with a prior VTE, 464 (10.14%) experienced recurrent PO VTE, corresponding to a 25-fold increase in odds compared with patients without prior VTE (odds ratio, 25.68; Conclusion: PO VTE occurred in fewer than 1% of patients after primary shoulder arthroplasty. Several comorbidities were associated with increased VTE risk, while prior VTE was the strongest predictor of recurrence. These findings may assist in identifying patients who warrant heightened perioperative VTE risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.